BioSpace News Archive

The global bioprocess analyzers market was valued at US$ 250 Mn in 2018 and is projected to expand at a CAGR of 10% from 2019 to 2027.

BioNTech SE and Pfizer Inc. have announced that the first cohort of BioNTech’s Phase 1/2 clinical trial has been dosed.

United Therapeutics Corporation announced its financial results for the quarter ended March 31, 2020.

Boston Scientific Corporation generated sales of $2.543 billion during the first quarter of 2020.

DaVita Inc. released its annual Community Care report, highlighting its commitment to corporate social responsibility and key clinical advancements in 2019..

LabCorp announced results for the first quarter ended March 31, 2020.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and for the prevention of certain infectious diseases, announced that it will report financial results for the first quarter ended March 31, 2020 on Wednesday, May 6, 2020 after the U.S. financial markets close.

Mechanisms of Action May Address Overactive Inflammatory Response, Including Underlying Causes of Blood Coagulation Disorders Associated with COVID-19

Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2020 on Wednesday, May 6 at 9 a.m. ET.

Adicet’s lead asset ADI-001 is an allogeneic gamma delta T cell therapy expressing a chimeric antigen receptor targeting CD20 for treatment of non-Hodgkin’s lymphoma